PSHG (PSHG) Stock Price & Analysis
PSHG (PSHG) rose 1.10% to USD 1.84 as of June 10, 2026 at 08:31 UTC, according to Nexqual real-time market data.
PSHG last closed at USD 1.82; the session ranged USD 1.78–1.85 on volume of 38,199 shares. Market capitalization is $22.88M, with a 52-week range of USD 1.62–2.58 (NCM). Source: Nexqual, June 10, 2026 at 08:31 UTC.
Key Statistics (as of June 10, 2026 at 08:31 UTC)
| Price | USD 1.84 |
|---|---|
| Change | ▲ 1.10% (up) |
| Previous Close | USD 1.82 |
| Open | USD 1.79 |
| Day Range | USD 1.78 – 1.85 |
| 52-Week Range | USD 1.62 – 2.58 |
| Volume | 38,199 shares |
| Market Cap | $22.88M |
| Exchange | NCM |
Technical Analysis (PSHG)
Nexqual's technical model rates PSHG "NEUTRAL" based on 3 bullish and 4 bearish signals across 123 daily candles, as of June 10, 2026 at 08:31 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 57.36 (neutral) |
| vs SMA50 | Above (USD 1.81) |
| MACD | -0.02 (negative) |
Analyst Ratings (PSHG)
Wall Street analysts rate PSHG "None" based on 2 analysts, with a mean price target of USD 5.75 (range USD 5–6.5), per Nexqual as of June 10, 2026 at 08:31 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 5.75 |
| High Target | USD 6.5 |
| Low Target | USD 5 |
Earnings (PSHG)
Source: Nexqual, June 10, 2026 at 08:31 UTC.
Financials & Fundamentals (PSHG)
| Total Revenue | $96.61M |
|---|---|
| Revenue Growth (YoY) | +58.30% |
| Gross Margin | +69.10% |
| Operating Margin | +44.68% |
| Profit Margin | +29.96% |
| ROE | +9.07% |
| Debt / Equity | 94.22 |
| Total Cash | $126.57M |
| Total Debt | $313.93M |
Source: Nexqual, June 10, 2026 at 08:31 UTC.
Financial Health Score (PSHG)
Nexqual rates PSHG's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 08:31 UTC.
| Growth | Strong — Revenue +58% YoY (latest Q) |
|---|---|
| Profitability | Strong — Gross margin 69%, operating 45% |
| Balance Sheet | Mixed — $127M cash vs $314M debt |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — ROE 9%, ROA 4.7% |
Ownership (PSHG)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +7.01% |
| Shares Outstanding | 12.43M |
| Float | 11.40M |
| Short % of Float | +3.71% |
Source: Nexqual, June 10, 2026 at 08:31 UTC.
Leadership (PSHG)
PSHG is led by Andreas Nikolaos Michalopoulos (age 54), MD, CEO, Secretary & Director, per Nexqual as of June 10, 2026 at 08:31 UTC.
| MD, CEO, Secretary & Director | Andreas Nikolaos Michalopoulos (age 54) |
|---|---|
| Chief Financial Officer | Anthony C. Argyropoulos (age 60) |
| Operations Director | Captain Nikolaos Gavalas |
| Technical Director | Argyris Chachalis |
| HSE Director | Captain Panos Chatzikyriakos |
Major Backers & Investors (PSHG)
Notable institutional backers of PSHG include Acadian Asset Management. LLC, Renaissance Technologies, NewEdge Advisors, LLC, according to Nexqual as of June 10, 2026 at 08:31 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Acadian Asset Management. LLC | 3.77% |
| Renaissance Technologies | 1.7% |
| NewEdge Advisors, LLC | 0.99% |
| UBS Group AG | 0.24% |
| Citadel | 0.24% |
Source: Nexqual, June 10, 2026 at 08:31 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| USEA | United Maritime Corporation | USD 2.59 | ▲ 4.86% |
| EDRY | EuroDry Ltd. | USD 22.27 | ▼ 0.62% |
| ILAG | Intelligent Living Application | USD 3.73 | ▲ 6.57% |
| PXS | Pyxis Tankers Inc. | USD 4.54 | ▼ 1.73% |
| QNRX | Quoin Pharmaceuticals, Ltd. | USD 4.95 | ▲ 10.24% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 08:31 UTC. This page is informational and not investment advice.